Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis-Reference-Cited by-同舟云学术

Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis

Published:2021-02-24 Issue:7 Volume:40 Page:1511-1516
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Strazzulla Alessio^ORCID,Postorino Maria Concetta,Youbong Tracie,Rouyer Maxence,Flateau Clara,Chakvetadze Catherine,de Pontfarcy Astrid,Pitsch Aurelia,Jochmans Sebastien,Belfeki Nabil,Monchi Mehran,Diamantis Sylvain

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-021-04184-8.pdf

Reference25 articles.

1. Lesho EP, Laguio-Vila M (2019) The slow-motion catastrophe of antimicrobial resistance and practical interventions for all prescribers. Mayo Clin Proc 94(6):1040–1047. https://doi.org/10.1016/j.mayocp.2018.11.005

2. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61–e111. https://doi.org/10.1093/cid/ciw353

3. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R (2017) International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latino Americana del Tórax (ALAT). Eur Respir J 50(3):1700582. https://doi.org/10.1183/13993003.00582-2017

4. Erdem H, Cag Y, Gencer S, Uysal S, Karakurt Z, Harman R, Aslan E, Mutlu-Yilmaz E, Karabay O, Uygun Y, Ulug M, Tosun S, Dogru A, Sener A, Dogan M, Hasbun R, Durmus G, Turan H, Batirel A, Duygu F, Inan A, Akkoyunlu Y, Celebi G, Ersoz G, Guven T, Dagli O, Guler S, Meric-Koc M, Oncu S, Rello J (2020) Treatment of ventilator-associated pneumonia (VAP) caused by acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 39(1):45–52. https://doi.org/10.1007/s10096-019-03691-z

5. Joffe AR, Muscedere J, Marshall JC, Su Y, Heyland DK, Canadian Critical Care Trials Group (2008) The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 23(1):82–90. https://doi.org/10.1016/j.jcrc.2007.12.006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Multidrug Resistant Bacteria Acquisition in Patients with Declared β-Lactam Allergy during Hospitalization in Intensive Care Unit: A Retrospective Cohort Study (2007-2018);Journal of Immunology Research;2022-01-12

2. Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Cohort Study;Antibiotics;2021-08-16